Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model
Keyword(s):
2016 ◽
Vol 30
(7)
◽
pp. 1300-1307
◽
Keyword(s):